Company intelligence / Profile preview

Peppy

London, England, United Kingdompeppy.health ↗

Ownership: Private
Development stage: Commercial

Overview

Peppy's digital platform is commercially deployed with over 250 enterprise clients globally. It provides personalized access to human clinical experts for menopause, fertility, pregnancy/parenthood, endometriosis, PCOS, and men’s health. The company has raised significant funding to expand in the US market after establishing a leading position in the UK. No clinical trial results apply as it is a service-based offering rather than a therapeutic product.

Therapeutic areas: OtherMen's HealthEndocrinologyWomen's Health
Modalities: Non-pharmacological therapyDigital health platformTelehealth services
Industry: Non-Academic Healthcare

Partnerships

Not specifically listed; works with over 250 enterprises including investment banks, law firms, pharmaceutical companies, media organizations, but no major pharma/biotech R&D partnerships.

Beyond the preview

Go deeper on Peppy.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peppy.

Explore the full profile